epsilon-Aminocaproic acid does not inhibit outflow resistance washout in monkeys.

Invest Ophthalmol Vis Sci

Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, USA.

Published: August 1995

Purpose: To determine whether the anti-fibrinolytic agent epsilon-aminocaproic acid (EACA) inhibits the washout of resistance to aqueous humor outflow during anterior chamber perfusion in cynomolgus monkeys, as it does in rabbits.

Methods: Nine adult ocular normotensive cynomolgus monkeys underwent bilateral anterior chamber perfusion with Bárány solution, containing 3.8 mM EACA unilaterally. Total outflow facility was determined in both eyes simultaneously for approximately 4 hours by the two-level constant pressure method. The data were analyzed using a linear regression model that tested treated versus control eye differences over time against a slope and intercept of 0.0.

Results: Outflow facility increased and resistance decreased significantly over time similarly in both EACA-treated and control eyes; i.e., neither the slopes nor the intercepts for facility or resistance, respectively, differed between the eyes over the entire 4-hour measurement period or for the initial 90 minutes considered separately. The facility increase and resistance decrease as functions of perfusion volume also were similar in EACA-treated and control eyes.

Conclusions: EACA at this dose does not prevent resistance washout in the cynomolgus monkey, in contrast to the rabbit. This species difference may relate to the vastly different anatomy and physiology of their outflow pathways.

Download full-text PDF

Source

Publication Analysis

Top Keywords

epsilon-aminocaproic acid
8
resistance washout
8
anterior chamber
8
chamber perfusion
8
cynomolgus monkeys
8
outflow facility
8
eaca-treated control
8
resistance
6
outflow
5
acid inhibit
4

Similar Publications

The search for new hemostatic materials remains a priority for researchers, as the problem of uncontrolled hemorrhage during surgical interventions or traumatic injuries represents a significant challenge. The objective of the study was to identify novel polysaccharide structures with enhanced hemostatic properties based on chitosan. The number of chitosan derivatives with two substituents was synthesized and characterized by H NMR, FTIR.

View Article and Find Full Text PDF

High-altitude pulmonary edema (HAPE) is a life-threatening altitude sickness afflicting certain individuals after rapid ascent to high altitude above 2500 m. In the setting of HAPE, an early diagnosis is critical and currently based on clinical evaluation. The aim of this study was to utilize the metabolomics to identify the altered metabolic patterns and potential biomarkers for HAPE.

View Article and Find Full Text PDF

Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening and life-limiting disease with high mortality and disability rates. Herein, we aim to explore the preventive effect of aminocaproic acid combined with nimodipine on short-term rebleeding in patients with aSAH. Retrospectively, the medical data of patients with aSAH ( n  = 256) were collected.

View Article and Find Full Text PDF

Computation-driven redesign of an NRPS-like carboxylic acid reductase improves activity and selectivity.

Sci Adv

November 2024

State Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, People's Republic of China.

Article Synopsis
  • - The study focuses on enhancing nonribosomal peptide synthetases (NRPSs) due to their significant potential in synthetic biology, despite limited knowledge of their functions.
  • - Researchers used computational methods to redesign the "gate-keeper" adenylation domain in a model enzyme, achieving substantial boosts in efficiency and specificity in converting certain acids.
  • - The findings suggest improved biocatalysts for producing nylon monomers and offer a new strategy for engineering NRPSs more effectively.
View Article and Find Full Text PDF
Article Synopsis
  • Fibrinolysis plays a crucial role in the release of hematopoietic stem cells from bone marrow, affecting the development of B-cell acute lymphoblastic leukemia (B-ALL).
  • Activation of plasmin, driven by annexin A2, alters the extracellular matrix (ECM), which impacts cancer cell growth by trapping the growth factor IGF1 and hindering signaling pathways.
  • Inhibiting plasmin activation with ε-aminocaproic acid (EACA) shows promise in reducing tumor size and extending survival in B-ALL models, suggesting that targeting fibrinolysis could be a helpful addition to cancer treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!